Home
>
National Drug Code (NDC)
>
Zonisamide
Zonisamide - 50268-815-11 - (Zonisamide)
Drug Information of Zonisamide
| Product NDC: | 50268-815 |
| Proprietary Name: | Zonisamide |
| Non Proprietary Name: | Zonisamide |
| Active Ingredient(s): | 100 mg/1 & nbsp; Zonisamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zonisamide
| Product NDC: | 50268-815 |
| Labeler Name: | AvPAK |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077636 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20051222 |
Package Information of Zonisamide
| Package NDC: | 50268-815-11 |
| Package Description: | 100 CAPSULE in 1 BOX, UNIT-DOSE (50268-815-11) |
NDC Information of Zonisamide
| NDC Code | 50268-815-11 |
| Proprietary Name | Zonisamide |
| Package Description | 100 CAPSULE in 1 BOX, UNIT-DOSE (50268-815-11) |
| Product NDC | 50268-815 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Zonisamide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20051222 |
| Marketing Category Name | ANDA |
| Labeler Name | AvPAK |
| Substance Name | ZONISAMIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
